Navigation Links
Hormone-Boosting Drug May Help Treat Frailty

Older adults who took capromorelin had boost in lean body mass

TUESDAY, Jan. 27 (HealthDay News) -- A drug designed to increase the body's production of growth hormone may help treat frailty in older adults, a new study shows.

Older adults have greatly reduced production of growth hormone, which regulates metabolism and helps build muscle mass. Age-related decreases in strength and physical agility can led to disability and loss of independence.

"By boosting the production of growth hormones, we may be able to slow this process and help people lead active lives longer," study first author Dr. Heidi K. White, an associate professor of medicine at Duke University Medical Center, said in a Duke news release.

The study included 395 women and men, aged 65 to 84, with mild physical function limitations. They were randomly selected to take either a placebo or one of four doses of the investigational drug capromorelin. All four doses of the drug increased growth hormone production, and the findings were sustained over one year of treatment.

The researchers also found that participants who took the drug showed a significant increase in lean body mass (1.4 kilograms vs. 0.3 kg for placebo) and improvements in two physical function tests -- tandem walking (heel to toe) and stair climbing. Fatigue, insomnia and small increases in fasting glucose and HbA1c scores were among the side effects noted among those who took the drug.

The findings were released online and were expected to be published in the April issue of The Journal of Clinical Endocrinology & Metabolism. The study was funded by Pfizer, which developed capromorelin.

While the results suggest that stimulating growth hormone production can increase the body's ability to develop lean muscle, the physical improvements seen in the study were relatively mild.

For example, the patients who took the drug showed a 7 percent increase in their ability to climb stairs. A previous study found that a home-based exercise program among a similar patient population achieved a 23 percent to 24 percent improvement in stair-climbing ability after 10 weeks.

"Following further investigation, capromorelin could be used in combination with exercise," White suggested.

More information

The AGS Foundation for Health in Aging has more about physical activity.

-- Robert Preidt

SOURCE: Duke University Medical Center, news release, Jan. 27, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. New treatment effective in counteracting cocaine-induced symptoms
3. New treatment boosts muscle function in myasthenia gravis
4. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
5. Free distribution of insecticide-treated mosquito nets can save lives
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
10. Non-medicinal treatment touted for pre-schoolers with ADHD
11. Nonmedicinal treatment touted for preschoolers with ADHD
Post Your Comments:
Related Image:
Hormone-Boosting Drug May Help Treat Frailty 
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: